Atorvastatin is a statin lipid-lowering medicine widely used to treat dyslipidemia and reduce cardiovascular risk. It is marketed under brand names including Lipitor and is taken orally. It has been approved in the U.S. since 1996 and is available as a generic prescription drug.
A major meta-analysis of 19 randomized trials involving 123,940 participants found that only six side effects are actually caused by statins, challenging long-standing concerns about the drugs' safety profile.
A 30-year-old female with stage IV gallbladder adenocarcinoma achieved complete metabolic resolution of metastases after three cycles of pembrolizumab, gemcitabine, and cisplatin, despite presenting without traditional risk factors.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07586540 |
Alirocumab for Stabilisation of Symptomatic Vulnerable Carotid Plaque |
NOT_YET_RECRUITING | PHASE3 |
| NCT07568574 |
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes |
ENROLLING_BY_INVITATION | NA |
| NCT07534592 |
A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants |
RECRUITING | PHASE1 |
| NCT07530289 |
A Clinical Study of Ulonivirine (MK-8507) With Atorvastatin and Metformin in Healthy Adults (MK-8507-018) |
RECRUITING | PHASE1 |
| NCT07502001 |
Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin |
NOT_YET_RECRUITING | PHASE1 |
| NCT07497776 |
Atorvastatin Therapy in the Treatment of Dyslipidemia in Children With Steroid Sensitive Nephrotic Syndrome |
COMPLETED | PHASE4 |
| NCT07474649 |
A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events |
NOT_YET_RECRUITING | PHASE3 |
| NCT07462715 |
Statins Against Bushfire Smoke |
NOT_YET_RECRUITING | PHASE4 |
| NCT07268625 |
Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid / Ezetimibe, and Atorvastatin |
COMPLETED | PHASE1 |
| NCT07235189 |
A Study Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin |
COMPLETED | PHASE1 |
